Lunai Bioworks Inc. SEC filings LNAI
Lunai Bioworks Inc. has 599 filings in SEC EDGAR's recent list, going back to Aug 12, 2011. Its latest annual report, Form 10-K, was filed on Oct 13, 2026 for the period ended Jun 30, 2026. The latest quarterly report (Form 10-Q) was filed on May 15, 2026, covering the quarter ended Mar 31, 2026. The most recent current report (Form 8-K) was filed on Oct 23, 2026 (listing notice, officer or director change, regulation fd disclosure, other events). The company's fiscal year ends on June 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 POS | Form s-8 pos | Oct 23, 2026 | — |
| POS AM | Form pos am | Oct 23, 2026 | — |
| S-8 POS | Form s-8 pos | Oct 23, 2026 | — |
| 424B5 | Prospectus supplement | Dec 3, 2025 | — |
| S-3 | Shelf registration | Oct 30, 2024 | — |
| S-8 | Employee stock plan registration | Oct 23, 2023 | — |
| S-3/A | Form s-3/a | Mar 3, 2022 | — |
| S-3 | Shelf registration | Feb 11, 2022 | — |
| S-8 | Employee stock plan registration | Dec 13, 2021 | — |
| 424B5 | Prospectus supplement | Jun 16, 2021 | — |
| 424B5 | Prospectus supplement | Jul 20, 2020 | — |
| S-3/A | Form s-3a | Jul 16, 2020 | — |
| S-3 | Shelf registration | Jul 13, 2020 | — |
| 424B3 | Prospectus | Oct 27, 2014 | — |
| 424B3 | Prospectus | Oct 15, 2014 | — |
| 424B3 | Prospectus | Aug 21, 2014 | — |
| 424B4 | Prospectus | Aug 14, 2014 | — |
| S-1/A | Amended registration statement | Aug 8, 2014 | — |
| S-1/A | Amended registration statement | Jul 25, 2014 | — |
| S-1/A | Amended registration statement | Jul 3, 2014 | — |
| S-1/A | Amended registration statement | Jun 23, 2014 | — |
| S-1/A | Amended registration statement | May 16, 2014 | — |
| S-1/A | Amended registration statement | Mar 31, 2014 | — |
| S-1 | Registration statement | Feb 14, 2014 | — |
Showing 24 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- LNAI (Nasdaq)
- Fiscal year ends
- June 30
- Incorporated in
- DE
- Headquarters
- Suite 906 Los Angeles, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1527728
- Former names
- RENOVARO INC. (until Aug 26, 2025); RENOVARO BIOSCIENCES INC. (until Feb 7, 2024); Enochian Biosciences Inc (until Aug 1, 2023); DanDrit Biotech USA, Inc. (until Feb 23, 2018); Putnam Hills Corp. (until Feb 11, 2014)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.